Introduction
Cytogenetic studies have previously identified abnormalities of chromosome band 11 q23 in many cases of infant acute leukemia. Recent studies by ourselves and others have demonstrated breakpoint clustering in acute leukemias bearing translocations involving I 1q23, and a Drosophila trithorax gene homologue (called MLL, HRX, or ALL-I) has been shown to span the 11q23 breakpoints of these translocations. To determine if this gene is affected in infant acute myeloid leukemia (AML), we have analyzed 26 infant AML cases for molecular alterations of this I 1q23 gene. 15 out of 26 cases studied (58%) showed rearrangement of the MLL gene at the molecular level, and these rearrangements were clustered within an -11-kb region containing nine exons of this gene. Moreover, 14 of the 15 cases with 11q23 rearrangements (93%) had myelomonocytic or monocytic phenotypes (M4 or M5 FAB subtypes, respectively), both of which are associated with a poor prognosis in childhood AML. In contrast, only 1 of 11 nonrearranged cases had an M4 or M5 phenotype (P = 0.00002). Rearrangement also correlated significantly with hyperleukocytosis (P = 0.02), another clinical parameter associated with poor outcome in this disease. Our results demonstrate that molecular rearrangements of MLL Acute myeloid leukemia (AML)' occurring in infants shows several important clinical differences when compared with AML in older children. First, AML is more prevalent among infants than older children, where lymphoblastic forms are much more common. In fact, AML is the most common form of acute leukemia occurring congenitally or within the first 4 wk of life (1) . Second, infant AML shows a higher incidence of myelomonocytic or monocytic phenotypes (M4 and M5 French-American-British [FAB] subtypes, respectively) (2, 3). Third, AML in infants is more commonly associated with hyperleukocytosis and extramedullary disease (4, 5) . Finally, cytogenetic studies have identified abnormalities ofchromosome band 1 lq23 in up to 45% of infant AML patients, while this finding is less frequent in older age groups (2, 3, 6) . These observations suggest that AML in infants may be biologically distinct from that occurring in older children.
Mechanisms of leukemogenesis in childhood acute leukemia remain largely unknown. The high incidence of cytogenetic abnormalities of 1 1q23 in infant cases suggests that this region may be critically important in infant acute leukemia. Nonrandom translocations or interstitial deletions involving band 1 q23 have previously been observed at the cytogenetic level in acute leukemia. Chromosomal bands involved in these translocations include 1q21, 2p21, 6q27, 9p22, 1Opl 1, 17q25, and l9p13 in AML (especially M4 and M5 subtypes), and 1 p32, 4q21, and l 9p 13 in acute lymphoblastic leukemia (ALL) (7, 8) . Similar translocations have also been observed in AML secondary to therapy with epipodophyllotoxins for the treatment of ALL (9) (10) (11) . At the molecular level, we (12) and others (13-15) have previously reported breakpoint clustering in acute leukemia cell lines or patients with 1 1q23 translocations. Moreover, transcriptional units spanning the 1 1q23 breakpoint region of cell lines with translocations involving chromosomal band 1 1q23 have been detected using probes from this region (13, 16) . Recently, the cloning and sequencing of cDNA species from tumor cells with the t(4;11), t(l1;19), ort (9;11 ) indicate that the same gene from llq23 is disrupted by these translocations (17) (18) (19) (20) . Sequence analysis of the 1 1q23 gene reveals potential zinc finger DNA binding motifs as well as DNA binding adenosine-thymidine (AT) hook motifs related to those of high mobility group proteins in the gene product (17) (18) (19) . This gene has been given several names, including myeloid/lymphoid leukemia (MLL) (13), acute lymphocytic leukemia-1 (ALL-I) (19) , and human trithorax (HRX) ( 18) , the latter in view of significant homology of the human gene with the trithorax homeobox gene of drosophila (17) (18) (19) . Fusion transcripts from the t(4;11), t( 1 l; 19) , and t(9;1 ) code for chimeric proteins containing the AT hook DNA binding motifs of the 1 1q23 gene product fused to previously undescribed proteins encoded for by genes located on the respective partner chromosomes (18) (19) (20) . To begin to analyze the clinical significance of alterations of the MLL gene, we have previously analyzed a series of infant ALL cases for molecular rearrangements ofthis locus, given the high incidence ofcytogenetic abnormalities ofband 1 1q23 in infant acute leukemia. In this prior study we found molecular rearrangements of the 1 lq23 gene in 21 of 30 (70%) infant ALL cases (21) . In fact, these alterations correlated with a significantly worse prognosis, and absence of rearrangement identified a group of infant ALL patients with a very good prognosis. Therefore, alteration ofthis gene may be involved in the pathogenesis of ALL in infants.
To confirm that MLL is also altered in infant AML, we have now performed Southern blot analysis ofclinical samples from a series of infant AML cases using probes derived from this locus. Our findings indicate that molecular rearrangements of MLL are indeed common in infant AML, and that these rearrangements map to the same region altered in infant ALL. Furthermore, rearrangements ofthis gene in infant AML are strongly correlated with monocytic or myelomonocytic phenotypes and with hyperleukocytosis, two parameters previously correlated with a poor prognosis in this disease.
Methods
Patients and cell lines. Bone marrow or peripheral blood specimens used in this study were obtained at the time of diagnosis from patients with AML. The selection ofAML samples for this study was based only on patients being < 1 yr of age at the time ofdiagnosis and availability of cryopreserved samples for analysis. All cases were enrolled in and treated with several Childrens Cancer Group (CCG) protocols as indicated in Table I , except where noted. The specific CCG protocols have been detailed elsewhere (22, 23 (25 ) . The B I cell line, also an ALL line with the t(4;1 1 )(q21;q23), was a generous gift from Dr.
MH Freeman (Sick Children's Hospital, Toronto, Ontario) (26) . The T-ALL cell line, MT, has been previously described (27 Statistical analysis. Cases were classified according to molecular analysis into two groups, one positive for 1 lq23 gene rearrangements and one negative for this finding. The two groups were compared with respect to various clinical and laboratory features using Fisher's exact test.
Molecular genetic studies. Probes used in this study are described elsewhere (21, 29) . Briefly, p98.40 and ps4 are single copy genomic probes located centromerically and telomerically, respectively, to the RS4; 11 derivative 11 chromosomal breakpoint. They were isolated from lambda subclones of a Washington University (St. Louis, MO) YAC clone containing the RS4; 1 breakpoint. The 4.2E probe is a subclone of the germline EcoRI restriction fragment located adjacent and telomeric to the EcoRI fragment recognized by ps4. The positions of the three probes in a germline map of the MLL locus are indicated in Fig. 2 . DNA was isolated from clinical samples using a modified protocol optimizing recovery from samples with limited material (30) . DNA isolated from RS4;I 1 or Bl cells was used as positive control DNA, and MT cell DNA was used as germline control DNA. Southern blot analysis was performed according to standard procedures using Nytran (Schleicher & Schuell, Inc., Keene, NH) or Hybond-N filters (Amersham Corp., Arlington Heights, IL). Probes were labeled to high specific activity with [32P]deoxycytidine triphosphate (dCTP) using the random primer method (31 ) . Membranes were stripped and tested for residual probe binding before hybridization with a different probe.
Experiments using 4.2E required the inclusion of 400 ,ug/ml total human placental DNA (Sigma Chemical Co., St. Louis, MO) in the hybridization solution to preanneal repetitive sequences recognized by this probe.
Results
High frequency of molecular rearrangements ofMLL in infant AML. We investigated 26 cases of infant AML (summarized in Table I ) for molecular rearrangements of the MLL-J gene by Southern blot analysis using p98.40, ps4, and 4.2E genomic probes. These probes are derived from a region containing exons 5-13 of this gene ( 19, Fig. 1 , a-e, 15 of 26 infant AML cases (58%) showed additional bands by Southern analysis using the above restriction enzymes and probes, indicating rearrangements of MLL. A summary of the results for all 26 infant AML cases studied is shown in Table III . As indicated, all rearranged cases showed alterations at 1 1q23 with at least two different restriction enzymes and at least two different probes. Moreover, a large number of negative control DNA samples did not show evidence of 1 1q23 gene rearrangements using the restriction enzymes and probes described in this study (data not ( 19, 29 ). This map also shows the breakpoint positions of the RS4;1 1 (24) and B1 (25) Patient  CD2  CD3  CD4  CD5  CD8  CD10  CD15  CD19  CD20  CD33  CD34  CD36  CD42b   Molecular   1   6  8  30  10  3  2  64  6  19  85  0  65  8   rearrangement  2  2  3  79  4  2  3  94  4  4  91  0  50   1   of I lq23  3  2  0  46  0  1  1  90  0  0  92  0  35  23  4  8  6  28  10  4  2  78  6  4  78  0  26  18  5  5  3  5  4  2  6  44  20  3  83  18  46  20  6  4  3  88  4  2  0  90  1  5  88  0  1  0  7  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  8  2  1 (17) (18) (19) (20) 29) . A number of previously analyzed breakpoints occurring in the region of exons 6-11 were found to lie between exons (19, 29) . Therefore, the breaks for cases 1, 3, 6, 7, 8, and 10-13 may similarly lie within intronic DNA. Alternatively, the breaks may occur within exons in this region ifthe donor and acceptor splice sites are complimentary and maintain the open reading frame in the resulting fusion gene. The breakpoint for case 14 does appear to occur within intronic DNA, in particular the SstI-EcoRI fragment lying between exons 8 and 9 (see Fig. 2 ). Less is known regarding breakpoints occurring after exon 11, but it is predicted that breaks in cases 2, 4, 5, 9, and 15 also maintain the open reading frame of derivative I1 fusion transcripts. It is not clear why cases 4 and 9 do not demonstrate rearrangements in EcoRI digests probed with 4.2E, given the fact that HindIll and BamHI rearrangements map the breakpoints of these cases to the telomeric-most BamHI-EcoRI fragment of Fig. 2 . This may be due to comigration of rearranged bands with germline fragments. Another possibility is that deletions of this region have occurred removing certain sequences recognized by 4.2E. Consistent with this are the smaller than expected sizes of HindIII fragments recognized by p98.40 and ps4 in these cases (see Table III ) and the finding by others that deletions of this locus occur in a significant proportion of cases with 1 1q23 translocations (33) . Of note, the rearrangements identified in this study occurred within the same region where we have previously observed clustered molecular rearrangements of MLL in 70% of 30 infant ALL cases, all but one of which showed the ALL-associated t(4;1 1 )(q21;q23) (21) . These findings, taken together, provide strong evidence that MLL is altered in a high percentage of infant acute leukemia cases.
We identified rearrangements ofMLL in all cases with cytogenetic evidence of 1 1q23 abnormalities. Cytogenetic alterations in these cases included a t(9;11)(p22;q23), t(l0;ll)(pI3;q23), t(lI;17)(q23;q25), t(ll;I9)(q23;pI3), MLL 
G, germline by molecular analysis; ND, not determined. * Cases 16 and 21 were both negative for rearrangement at 11 q23 when analyzed by pulse-field gel electrophoresis of BssHII-digested DNA using p98.40 and ps4 probes. and a del( 11 )(q23), each of which has been previously described in childhood AML (7, 8) . Therefore, involvement of this gene appears to be common to a diverse group of cytogenetic alterations of chromosome band 1 1q23 in infant AML. Overall, concordance between cytogenetic and molecular 1 1q23 findings was observed in 13 (76%) of the 17 cases with adequate cytogenetic analyses. Additionally, however, molecular rearrangements were observed in four cases (nos. 6, 7, 10, and 15) lacking detectable cytogenetic alterations of 1 1q23. In fact, the high incidence of molecular genetic alterations of 1 lq23 described here for infant AML is greater than that predicted by several cytogenetic studies of this disease, in which 20-45% of infants with AML showed cytogenetic abnormalities of band 1 1q23 (2, 3, 6) . This increased sensitivity of molecular analysis may be explained by the presence of submicroscopic alterations involving MLL detected only at the molecular level. The utility of using molecular analysis of the 1 1q23 region is particularly important in infant acute leukemia given the relative difficulty in obtaining adequate bone marrow samples from these patients for cytogenetic studies and the low mitotic index often observed in infant leukemic marrow specimens. Given the high incidence of molecular rearrangements ofMLL observed in this study and the relative ease ofperform- Not available Not available 46,XX,t(7;l 1lXp22;q23) [26] /46,XX [5] 46,XX,t(9;l lXp22;q13) [20] 47,XX,+6,del(l 1Xq21),add(22Xq 13) [15] 46,XX,t(1 1; 7)(q23;q25) [14] 46,XY,t(l0; 11 Xp13;q23) [17] /46,XY [4] 46,XX,der (5) [6] ing Southern analysis on limited samples, as described here, we recommend that molecular analysis of this gene locus be performed in addition to cytogenetics in the diagnostic work-up of infant AML cases. It has been demonstrated previously that many acute leukemias with monocytic or myelomonocytic morphology show cytogenetic evidence of lq23 abnormalities (34, 35) . This, along with the fact that t(4; 1 1 ) ALL cases often show biphenotypic features with coexpression of both lymphoid and myelomonocytic antigens (36, 37) (38) . These studies show a high incidence of cytogenetic abnormalities of 1 1q23 in therapy-related AML (9-11 ) and, more recently, rearrangements of the MLL gene in these leukemias (39) . Moreover, there appears to be a strong correlation between 11 q23 abnormalities and an M4 or M5 phenotype in the secondary leukemias (9) (10) (11) . The trithorax gene product of drosophila is characterized by zinc finger DNA binding domains and functions as a transcriptional regulator of homeotic genes involved in the control of segmentation and embryogenesis in the fly ( 1 7, 18 Our studies demonstrate that molecular rearrangements of MLL are common in infant AML and that molecular analysis ofthis gene appears to be more sensitive than cytogenetic evaluation for the detection of 1 1q23 abnormalities in some patients with this disease. The correlation of both M4/M5 phenotype and hyperleukocytosis with rearrangements of MLL indicates that this genetic alteration may be associated with a poor prognosis in infant AML. Furthermore, the high frequency of these rearrangements in M4 and M5 subtypes suggests that the presence of an altered version of this gene may result in abnormal control of proliferation and differentiation in precursor cells of the monocytic lineage. It is hoped that detailed analysis of MLL in infant AML will reveal fundamental insights into the leukemogenic process in this disease.
